Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations
Pharmacogenomics · 2023
DOI: 10.2217/pgs-2023-0166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacogenomics, 2023. Verfasst von Ross P Booyse und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, National Health Laboratory Service, and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand,…. Hauptthemen laut MEDLINE: Pharmacogenetics, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, University of the Witwatersrand, Sydney Brenner Charitable Trust.
Abstract (Originalsprache)
Background
CYP2C19 is important in the metabolism of clopidogrel and several antidepressants. This study aimed to characterize the distribution of CYP2C19 star alleles (haplotypes) across diverse African populations compared with global populations.
Methods
CYP2C19 star alleles and diplotypes were called from high coverage genomes using the StellarPGx pipeline.
Results
CYP2C19*1 (51%), *2 (17%) and *17 (22%) were the most common star alleles across African populations in this study. It was observed that 3% of African participants had potentially novel CYP2C19 haplotypes.
Conclusion
This study supports the necessity for CYP2C19 pharmacogenetic testing in African and global clinical settings, as well as the importance of comprehensive star allele characterization in the African context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Genetics, National Health Laboratory Service, and School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- School of Electrical & Information Engineering, University of the Witwatersrand, Johannesburg, South Africa.
ORCID-Profile: Ross P Booyse, David Twesigomwe, Scott Hazelhurst
Förderung
- NHGRI NIH HHS
- University of the Witwatersrand
- Sydney Brenner Charitable Trust
- NIH/NHGRI
Zitieren
APA
Booyse, R. P., Twesigomwe, D., & Hazelhurst, S. (2023). Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations. Pharmacogenomics. https://doi.org/10.2217/pgs-2023-0166
Vancouver
Booyse RP, Twesigomwe D, Hazelhurst S. Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations. Pharmacogenomics. 2023. doi:10.2217/pgs-2023-0166
BibTeX
@article{Booyse2023,
author = {Booyse, Ross P and Twesigomwe, David and Hazelhurst, Scott},
title = {Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations},
journal = {Pharmacogenomics},
year = {2023},
doi = {10.2217/pgs-2023-0166}
}
EUVIMED